Journal
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE
Volume 5, Issue 3, Pages 107-111Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/1759720X13477714
Keywords
bisphosphonates; drug holidays; fractures; osteoporosis
Categories
Ask authors/readers for more resources
Bisphosphonates have been widely used in the treatment of osteoporosis with robust data from numerous placebo-controlled trials demonstrating efficacy in fracture risk reduction over 3-5 years of treatment. Although bisphosphonates are generally safe and well tolerated, concerns have emerged about adverse effects related to long-term use. For most patients with osteoporosis, the benefits of treatment outweigh the risks. Because these agents accumulate in bone with some persistent antifracture efficacy after therapy is stopped, it is reasonable to consider a 'drug holiday.' There is considerable controversy regarding the optimal duration of therapy and the length of the holiday, both of which should be based on individual assessments of risk and benefit.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available